High Court to rule on whether NHS England should fund new preventative HIV drug PrEP The High Court is due to rule on whether the NHS should fund a“game-changing” preventative treatment for HIV in England.
Pre-exposure prophylaxis, known as PrEP, is an anti-retroviral drug used to stop HIV from becoming established in the event of transmission.
When taken consistently, it has been shown to reduce the risk of infection in people who are at high risk by more than 90 per cent. The Independent
See also:
Pre-exposure prophylaxis, known as PrEP, is an anti-retroviral drug used to stop HIV from becoming established in the event of transmission.
When taken consistently, it has been shown to reduce the risk of infection in people who are at high risk by more than 90 per cent. The Independent
See also:
- Court ruling on HIV 'game-changing' drug BBC News
- 'Confidence to trust' BBC News
No comments:
Post a Comment